Shingrix may be prescribed in 93 general hospitals in Korea
By Eo, Yun-Ho | translator Kim, Jung-Ju
23.02.24 06:00:01
가나다라
0
Passes drug committees of various medical institutions including SMC, SNUH
Proven to be over 90% effective in preventing shingles in clinical trials
According to industry sources, GSK Korea’s recombinant vaccine Shingrix passed review by drug committees of 93 medical institutions in Korea, including tertiary hospitals - Samsung Medical Center, Seoul National University Hospital, Asan Medical Center - as well as general hospitals - Kangbuk Samsung Medical Center, Kyung Hee University Medical Center, Korea University Hospital (Buro, Anam, Ansan), Soonchunhyang University Hospital Seoul, Ajou University Hospital, and Hanyang University Hospital.
Considering how vaccination had started in December in earnest, the vaccine ha
Eo, Yun-Ho(unkindfish@dailypharm.com)
If you want to see the full article, please JOIN US (click)